Teva Pharmaceuticals
Generic and Specialty Pharmaceuticals
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
Teva Pharmaceuticals | 03/03/2021 | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) | 01/01/1901 | "500+" |
Teva Pharmaceutical Industries is a global pharmaceutical company that develops, produces, and markets generic drugs, specialty pharmaceuticals, and active pharmaceutical ingredients.
Headquartered in Israel, Teva has a product portfolio of more than 3,500 medicines and produces approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. Teva is ranked among the leading pharmaceutical companies in the world and is active in 60 countries, with approximately 43,000 employees worldwide.
Teva's areas of focus are specialty medicines, generic medicines, and active pharmaceutical ingredients.
Combating Coronavirus Pandemic:
Teva has continuously worked since the early days of the COVID-19 pandemic to support efforts of governments and health services to curb the impact of the virus. Its global manufacturing network has been focused on securing and scaling production of both API and finished doses for potential treatments that may prove essential in treating the condition nearly everywhere Teva does business.